A new, simplified technique for the synthesis of polyethylene glycol (PEG) derivatives of proteins utilizing l.l'-carbonyldiimidazole for PEG activation, is described. PEG derivatives of superoxide dismutase, cw,-macroglobulin. ol,-macroglobulin-trypsin, and lactoferrin were prepared and studied. Superoxide dismutase coupled to PEG preserved 95% of its original activity while its plasma half-life increased from 3.5 min to 9 or more hours depending on the PEG derivative studied. PEG-derivatized cYz-macroglobulin showed decreased protease binding activity but PEG derivatives of preformed az-macroglobulin-trypsin demonstrated no loss of activity. The plasma clearance of PEG-oc*-macroglobulin-trypsin was prolonged significantly compared to native c*2-macroglobulin-trypsin, particularly when a high-molecular-weight PEG was coupled to the protease inhibitor complex.
The plasma clearance half-life of lactoferrin was increased 5-to 20-fold by this modification.
Trinitrobenzenesulfonic acid titration studies demonstrated that c-amino groups of lysine residues are modified by the coupling of carbonyldiimidazole-activated PEG to proteins.
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The hydroxyl groups of monomethoxypolyethylene glycols (HO(-CH2-CH2-0-), CH3) may be activated by cyanuric chloride and several other reagents and then coupled to lysine t-amino groups of proteins (l-5). Polyethylene glycol-protein adducts demonstrate increased blood circulation time and decreased antigenicity and immunogenicity as compared to the unmodified proteins (1, (6) (7) (8) (9) (10) (11) (12) . Derivatized proteins, however, often demonstrate a marked loss of activity (8,lO) .
1, I'-Carbonyldiimidazole reacts with the hydroxyl groups on agarose to produce a derivative that reacts with nucleophiles (13) . In the present manuscript a simple procedure is described for activating polyethylene glycol with this reagent. Reactions with monofunc- ' To whom all correspondence should be addressed.
tional (PEG-2 and PEG-5),2 bifunctional (PEG-4) and tetrafunctional (PEG-20) polymers containing one, two, and four hydroxyl groups, respectively, are compared.3 Polyethylene glycols activated with this reagent couple to lysine residues as with other activated polyethylene glycols. The proteins derivatized with the activated polyethylene glycols include bovine liver copper-zinc superoxide dismutase, human plasma a*-macroglobulin complexed with trypsin, and human milk lactoferrin. These proteins are representative of three mechanisms of plasma clearance. Superoxide dismutase, Mr = 3 1,200, catalyzes the disproportionation of 0; (14) . Clearance from the mammalian circulation results from passive diffusion of the relatively small protein through the renal glomeruli (15) . Lactoferrin is an iron-binding protein found in the granules of neutrophils which may play an important role in tissue injury mediated by phagocytes ( 16) . It is rapidly cleared from the circulation by hepatocytes as a result of carbohydrate recognition ( 17) . a*-Macroglobulin is a high-molecular-weight plasma protease inhibitor (18). Following reaction with a protease, the complex is recognized by receptors in the reticuloendothelial system and rapid clearance occurs ( 19) . The receptor recognition site is present on the inhibitor and most likely involves a sequence of amino acids which either becomes exposed or assumes an appropriate conformation after reaction with protease.
The clearance rates of the native and polyethylene glycol-derivatized forms of these proteins are compared in mice. The results of in vitro activity experiments are also presented. Using published data and these studies, a comparison is made of some of the advantages and disadvantages of the cyanuric chloride and 1, I'-carbonyldiimidazole procedures for synthesis and polyethylene glycolprotein derivatives. (19) of the method of Kurecki et al. (22) . All other reagents were the best commercial grade available.
Electrophoresis. Native polyacrylamide gel electrophoresis was performed on 5% slabs with the continuous Tris-borate system of Nelles et al. (23) or on 7.5% gels using the discontinuous buffer system of Davis (24) . Gels were stained with Coomassie brilliant blue G-250.
Enzyme activity assays. SOD activity was measured according to the procedure of McCord and Fridovich ( 14) . The ability of a2M to bind trypsin following reaction with PEG was studied with a modification of the method of Ganrot (28) . A detailed description of the procedure is presented elsewhere (29) . In other experiments, azM-trypsin complex was preformed and then reacted with activated PEG. BAPNA substrate was added and amidolytic activity was assayed.
Protein concentrations. The concentrations of unmodified proteins were calculated using the following extinction coefficients and molecular weight determinations:
(YAM, @& 280 nm = 8.93, M, = 718,000 (25) lactoferrin, At:,, 28o ",,, = 10, M, = 77,000 (21), bovine copper-zinc SOD, A is&,, 28o ",,, = 2.70, M, = 3 1,200 (14, 26) . The concentration of PEG-modified protein was estimated by the Biuret procedure (27) . The unmodified proteins served as standards.
Purljication of bovine liver copper-zinc SOD. The procedure of McCord and Fridovich ( 14) for isolating SOD from bovine erythrocytes was modified for a bovine liver source. All steps were performed at 4°C unless otherwise specified. Fresh bovine liver (900 g) was homogenized in a Waring blender for 2 min in 2 liters of deionized water and then filtered through cheese cloth. Ethanol (0.25 vol) and chloroform (0.15 vol) were added with stirring and the mixture centrifuged (9200g) for 30 min. To the supernatant, 300 g/liter of anhydrous K2HP04 was added with stirring and the preparation was centrifuged for 20 min at 2 1 ,OOOg. The supernatant was placed in a separatory funnel and the upper ethanol phase was collected and centrifuged for 20 min at 2 1 ,OOOg. The supernatant was again placed in a separatory funnel to remove and discard residual lower phase. The upper ethanol phase containing SOD activity was rapidly cooled to between -2 and -5°C in a salt-ice bath and 0.75 vol of acetone at -20°C were added with stirring. The mixture was immediately centrifuged (2 1 ,OOOg) for 20 min and the precipitate collected and dispersed with a Tenbroek homogenizer in 100 cm3 cold deionized H20. Ammonium sulfate (32.6 g/l00 ml) was added, the mixture centrifuged (2 1 ,OOOg) for 20 min, and the precipitate discarded. The supernatant was dialyzed against 2.5 mM KP,, pH 7.45 and applied to a DE-52 column (2.5 X 35 cm) equilibrated in the same buffer at 4°C. The column was eluted sequentially at pH 7.45 with 250 ml each of 2.5 mM Kp,, and 10 mM KI'i with 7 ml fractions collected at 2 ml/min. SOD eluted from the column at the 10 mM KP; step. Purity of the fractions was determined by polyacrylamide gel electrophoresis. Fractions containing pure SOD were pooled. Fractions containing significant amounts of impure SOD were pooled and rechromatographed on the same DE-52 column. The presence of two to three SOD isoenzymes was verified by comparison of gels stained for protein with gels stained for SOD activity (30). The purified SOD had a specific activity of 3200 units/mg using the activity assay of McCord and Fridovich (14) Activation of PEG. The PEG was dissolved in dioxane at 37°C at a concentration of 50 mM (PEG-2, PEG-4, and PEG-5) or 5 mM (PEG-20) and 1 , 1'-carbonyldiimidazole added to a final concentration of 500 mM. The solution was incubated at 37°C for 2 h with stirring and then dialyzed extensively against Hz0 at 4°C. The activated PEG-2, PEG-4, and PEG-5 solutions were dialyzed in Spectrapor dialysis membranes with 1000,2000, and 3500 M, inclusion limits, respectively, and the activated PEG-20 solution was dialyzed in a dialysis membrane with a 10,000 A4, inclusion limit. The solutions were then lyopholized and stored dessicated at 4°C. The resultant powder constituted "activated PEG."
Elemental analysis of activated PEG derivatives. Analysis for percent hydrogen, carbon, oxygen, and nitrogen content of the activated PEG derivatives was performed by Spang Microanalytical Laboratory (Eagle Harbor, Mich.).
TNBS titration studies. The percentage of SOD amino groups that reacted with the activated PEG was determined using the TNBS titration procedure described by Glazer et al. (33) . Prior to the TNBS titration, the PEG-SOD adducts were dialyzed in tubing with a 50,000 A4, cutoffand concentrated in an Amicon ultrafiltration apparatus with an XM-50 membrane.
Coupling of activated PEG to proteins. Ac- h. At 48 h, the concentration of activated PEG-5 was increased to 180 tnM and the incubation continued for another 48 h. In other studies, 180 mM PEG-5 was present for the entire 96-h incubation.
Trypsin was incubated with radiolabeled azM in 10 IIIM sodium borate, pH 8.5, for 5 min at room temperature at a trypsin to protease inhibitor ratio of 2. Activated PEG-2, PEG-4, and PEG-5 (40 mM) were incubated with 1 X 10e6 M azM-trypsin complex in the same buffer for 72 h. Activated PEG-20 (10 mM) was incubated with 5 X lo-' M azMtrypsin complex for 72 h. Uncomplexed azM was reacted with PEG under similar conditions. Activated PEG-2 or 4 (40 or 160 mM) and radiolabeled lactofetrin (4 X 10e6 M) were incubated in 10 mM sodium borate, pH 8.5, at 4 C" for 72 h.
Clearance studies. Clearance studies were performed in 20-week-old CD-1 female white mice as previously described (19, 34) . Studies were generally performed in triplicate and the results averaged. Each individual study varied by less than 5% compared to the mean.
RESULTS
Elemental analysis of activated PEG derivatives. The expected product of the reaction of 1 , 1'-carbonyldiimidazole with the hydroxyl group of PEG is an imidazole carbamate derivative ( 13) . Figure 1 illustrates the proposed structure of activated PEG formed by this procedure. The nitrogen content for each of the activated PEG derivatives was calculated using this general structure, and the predicted value compared to the actual content determined by elemental analysis of the activated PEG derivatives (Table 1) . For each of the activated PEG derivatives, experimental nitrogen content was essentially identical to the calculated percent nitrogen from the structure of activated PEG in Fig. 1 .
TNBS titration of the PEG derivatives of SOD. TNBS titration was performed to determine if amino groups of the PEG-derivatized protein were modified as predicted by the structure of the PEG-protein adduct given in Fig. 1 . The PEG-4 and PEG-5 derivatives of SOD were extensively dialyzed in 50,000 M, inclusion limits dialysis tubing and concentrated using a filtration membrane with a similar cutoff to remove PEG which interferes with TNBS titration (data not shown). The TNBS titration results showed the PEG-4 derivative of SOD had 5% and the PEG-5 derivative 10% titratable amino groups as compared to the unmodified protein.
Gel electrophoresis of PEG modified SOD. Polyacrylamide gel electrophoresis was used to demonstrate that incubation of activated PEG with SOD produces an altered form of the enzyme and to study the effect of different incubation conditions on the formation of a PEG-SOD adduct. The effect of two different control value. In control experiments, unreacted PEG had no effect on the activity of a*M-trypsin when added simultaneously with the substrate BAPNA. Trypsin amidolytic activity is increased after PEG derivatization using the cyanuric chloride procedure (35) . The present results may represent a similar phenomenon.
Electrophoresis of PEG-modijied (YAMtrypsin complex. Figure 4 shows a comparison between the electrophoretic mobilities in a native electrophoresis system of unmodified and PEG-modified crzM-trypsin complex. The PEG derivatives of qM-trypsin complex distributed in a broader band than unmodified azM-trypsin suggesting some heterogeneity in the population of derivatives. The de- creased mobilities of the derivatives most likely reflect decreased positive change and increased size as was the case for SOD.
Clearance of PEG-modified a2A4-trypsin complex. Figure 5 shows the clearance of qMtrypsin complex before and after reaction with activated PEG. The clearance of unmodified cu2M-trypsin complex was rapid in agreement with previous studies (19, 34) . The PEG derivatives of azM-trypsin complex cleared at a decreased rate. Reactions with higher molecular weight PEGS resulted in a more pronounced inhibition of clearance. The apparent half-life of the PEG-20 derivative approached that of the unreacted inhibitor.
Clearance of PEG-modified lactoferrin. modified lactoferrin. The half-life increased from less than 3 min for unmodified lactoferrin to 15 min for the PEG-Zmodified protein and to 60 min for the PEG-4 derivative. Unlabeled native lactoferrin significantly competed for clearance with the PEG-2 derivative of radiolabeled lactoferrin. When a 3000-fold molar excess of unlabeled native lactoferrin was injected with the radiolabeled derivative, the clearance of the derivative was prolonged fivefold. This result suggests that the derivatized protein clears on the same hepatocyte receptor that clears native lactoferrin (17) . Lactoferrin precipitated when incubated with 40 mM PEG-5 or greater than 160 mM PEG-2 or PEG-4. Electrophoresis confirmed that the precipitates contained lactoferrin. Precipitated lactoferrin when redissolved cleared at a rate typical of the unmodified protein suggesting that no derivatization occurred. PEG is capable of precipitating many proteins without denaturation (36) and it appears likely that this phenomenon was observed under these reaction conditions.
DISCUSSION
Proteins are increasingly important in clinical medicine as drugs, but many of these proteins must be obtained from nonhuman sources since insufficient amounts can be purified from available human tissue or, for example, as in the case of streptokinase, the protein is not synthesized by eukaryotic organisms (see Ref. (34) for a discussion of the uses of streptokinase). This raises the problem of protein antigenicity. A second problem encountered when proteins are used as drugs is the short half-lives of many of these preparations. As an example, streptokinase has a half-life of only about 15 min (34) .
Two interesting characteristics of some PEG-protein adducts, as compared to the unmodified proteins, are an increase in blood circulation time and a decrease in antigenicity and immunogenicity ( 1, 6) . Unfortunately, the coupling of PEG to proteins often results in substantial loss of activity. The coupling of cyanuric chloride activated PEG to SOD results in an approximate loss of 50% of the activity. Modification of L-glutaminase-L-asparaginase results in loss of almost 90% of its activity (6,lO) .
This report describes a new technique for linking PEG polymers to proteins by using an easily prepared carbonyldiimidazole-activated PEG. The formation and isolation of the activated PEG is a simple three-step procedure consisting of incubating carbonyldiimidazole with PEG in a nonaqueous solvent, dialyzing the product against water, and lyophilizing the preparation. The resultant "activated PEG" is an imidazole carbamate derivative of the hydroxyl group of the polymer as illustrated in Fig. 1 for a monofunctional PEG. Support for this proposed structure was obtained by elemental analysis.
The proteins derivatized with the activated polyethylene glycols were chosen to represent three different mechanisms of plasma clearance; namely, passive excretion (SOD), recognition of unique amino acid recognition sites by a receptor (azM-trypsin), and carbohydrate recognition by receptors (lactofertin) (15, 17, 19) . Two of these proteins have the additional advantage of possessing an enzyme activity (SOD) and a protease binding function (cQM), which can be evaluated after PEG modification.
The antigenicity or immunogenicity of PEG adducts prepared by use of carbonyldiimidazole-activated PEG was not evaluated. These properties are not predictable a priori and must be evaluated for each PEG-protein adduct prepared by any of the reported coupling procedures.
When SOD was incubated with a 3600-fold molar excess of activated PEG-4 or PEG-5, less than 10% of the free amino groups remained. This compares favorably with cyanuric chloride-activated PEG-5 derivatization of SOD (8) . The PEG-4 adduct of SOD made with carbonyldiimidazole-activated PEG had greater than 95% of the activity of native SOD and a blood circulation half-life of 16 h. The PEG adduct of SOD made with cyanuric chloride-activated PEG had a similar half-life, but as described above, retained only 5 1% catalytic activity (8) .
There was also a striking change in the blood circulation half-life of lactoferrin after derivatization with carbonyldiimadazole activated PEG. Native lactoferrin competed for the clearance of a radiolabeled PEG-lactoferrin complex consistent with the clearance of the modified derivative by the same mechanism which clears the native protein, albeit at a slower rate.
The ability of PEG-modified LY~M to bind trypsin was decreased significantly, presumably because of steric hindrance in the interaction of the PEG modified qM with trypsin. PEG modification of preformed azM-trypsin, however, yielded derivatives which did not demonstrate loss of amidolytic activity. Clearance studies of cyzM-trypsin demonstrated that a relatively large polymer (PEG-20) was necessary to cause an increase in the plasma half-life in contrast with the PEG derivatives of SOD and lactoferrin. The plasma clearance of PEG-20-azM-trypsin actually approached that of the native molecule.
The plasma clearances of the PEG adducts of SOD, lactoferrin, and azM-trypsin were generally biphasic while the clearances of the native ligands were essentially first order. This difference probably reflects some heterogeneity in the extent of protein modification. The comparisons, therefore, of the half-lives of modified and unmodified proteins is somewhat misleading since it tends to underestimate the actual increase in the circulating halflives of the modified proteins. This was particularly evident for the PEG derivatives of lactoferrin where the apparent half-life increased from about 3 min for the reactive molecule to 15 min (PEG-2) and 60 min (PEG-4) respectively. In each case, 50 to 75% of the modified protein population actually demonstrated a plasma clearance of several hours.
These studies document the utility of carbonyldiimidazole-activated PEG as a cou- 
